(RTTNews) – AstraZeneca(AZN, AZN.L, ZEG.DE, AZN.ST) and Daiichi Sankyo Company’s (4568.T) ENHERTU has been approved by the US Food and Drug Administration (FDA) for both neoadjuvant or use before surgery and adjuvant or use following surgery treatment of patients with HER2-positi